Jindřich Špinar
- Cardiology and Cardiovascular Medicine top 5%
- Surgery
- Radiology, Nuclear Medicine and Imaging top 10%
- Internal Medicine top 5%
- Epidemiology
- Co-authors
- Jiří PařenicaKateřina HelánováJiří VítovecLenka ŠpinarováMonika Pávková GoldbergováDavid A. MorrowSabina A. MurphyMarc S. Sabatine
- Topics
- Heart Failure Treatment and Management (30 papers)Cardiovascular Function and Risk Factors (19 papers)Atrial Fibrillation Management and Outcomes (12 papers)
- Partner nations
- CzechiaUnited StatesFrance
In The Last Decade
Jindřich Špinar
97 papers receiving 794 citations
Hit Papers
Peers
Comparison fields: 5 of 82
- Cardiology and Cardiovascular Medicine 616
- Surgery 141
- Radiology, Nuclear Medicine and Imaging 121
- Internal Medicine 94
- Epidemiology 86
Countries citing papers authored by Jindřich Špinar
This map shows the geographic impact of Jindřich Špinar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jindřich Špinar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jindřich Špinar more than expected).
Fields of papers citing papers by Jindřich Špinar
This network shows the impact of papers produced by Jindřich Špinar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jindřich Špinar. The network helps show where Jindřich Špinar may publish in the future.
Co-authorship network of co-authors of Jindřich Špinar
This figure shows the co-authorship network connecting the top 25 collaborators of Jindřich Špinar. A scholar is included among the top collaborators of Jindřich Špinar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jindřich Špinar. Jindřich Špinar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillationbreakdown → | 31 |
| 2 | 4 | |
| 3 | 3 | |
| 4 | 1 | |
| 5 | Bisoprolol a perindopril - optimální kombinace pro nemocné sICHS a srdečním selháním | 1 |
| 6 | 43 | |
| 7 | [SAVOR TIMI 53 - Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus]. | 11 |
| 8 | [Inflammatory response and C -reactive protein value in patient with acute coronary syndrome]. | 10 |
| 9 | Sekundární prevence po infarktu myokardu - režimové a farmakologické postupy | 2 |
| 10 | Je farmakoterapie po infarktu myokardu dostatečná | 0 |
| 11 | 1 | |
| 12 | Doporučení pro diagnostiku a léčbu srdečního selhání ČKS 2006 | 1 |
| 13 | Doporučení pro diagnostiku a léčbu akutního srdečního selhání. | 6 |
| 14 | Co by měl internista vědět o diastolickém srdečním selhání | 0 |
| 15 | VALIANT - Valsartan, captopril nebo obojí u infarktu myokardu komplikovaného srdečním selháním a/nebo dysfunkcí levé komory - samostatně ano, společně ne | 1 |
| 16 | Mohou blokátory receptorů pro angiotenzin II (AIIA) nahradit vléčbě srdečního selhání inhibitory ACE | 2 |
| 17 | Který betablokátor u srdečního selhání?Studie COMET - dalajasnou odpověď? | 1 |
| 18 | The value of big endothelin level and hemodynamic variables inheart transplant candidates | 3 |
| 19 | Hypertension and combination drug therapy. | 2 |
| 20 | Blokátory receptoru 1 pro angiotenzin II v léčbě chronickéhosrdečního selhání | 2 |
About Jindřich Špinar
Jindřich Špinar is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Internal Medicine, having authored 127 papers that have together received 834 indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (30 papers), Cardiovascular Function and Risk Factors (19 papers) and Atrial Fibrillation Management and Outcomes (12 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (616 citations), Internal Medicine (94 citations) and Nephrology (53 citations). Jindřich Špinar has collaborated with scholars based in Czechia, United States and France. Frequent co-authors include Jiří Pařenica, Kateřina Helánová, Jiří Vítovec, Lenka Špinarová, Monika Pávková Goldbergová, David A. Morrow, Sabina A. Murphy, Marc S. Sabatine, Benjamin M. Scirica and Anthony J. Dalby. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.